Member Info for dusterinmong

Nothing to do with your carp dolls head

The way to make money is buy low sell higher

Identify a company that for reasons has fallen or cheap examples covid, or other world events that has reduced the price.

Wait for the right entry then buy when you identify that the event has started to reverse or a company has solved it's issues.

Set a disciplined exit point and stick to it . Nobody gets poor taking a profit

This company has all the makings of a solid return to former highs starting now.

A brand name not an AIM casino stock this will be not lost once momentum builds past 32p

Lastly one doll head on a bb makes not one jot to where this is heading short med long term

Target for myself is 46p before EOY

ATB

Don't let them bore you out of your stock

The company is “in discussions with a number of larger medtech companies” over licensing the product and sending samples to its laboratories, he said on the conference call.

These potential contracts, some of which he said are with “billion-dollar revenue pharma”, represent potentially several thousand samples taken over a number of years.  

And that's the very reason why the market makers will dance this around looking for stock of the weak

Cawkwell comments... Those gentlemen at Hobart, Bob Catto and Jeremy Lyon, frequently extolled the prospects at Angle (AGL). However, they are both now dead and cannot cheer on AGL. This is a pity since yesterday’s RNS advising that America’s FDA have cleared AGL’s liquid biopsy approach to identifying and monitoring cancer, particularly if it is metastasising, is a huge breakthrough. The saving in costs is truly massive. Just who the customers will prove to be and at what price remains to be seen but the revenues generated will surely swamp the current c. £400m capitalisation. Guesses as to future share prices vary. But first stop seems to me to be well over 200p. And there is a section of the market that reckons 500p and more is just the beginning.

EUROPE RESEARCH ROUNDUP – Galp Energia SA, Next, Novozymes
26 May 2022 12:32
May 26 (Reuters) – Securities analysts revised their ratings and price targets on several European companies, including Galp Energia SA, Next and Novozymes, on Thursday.

Highlights
Galp Energia SA : RBC raises to outperform from sector perform * Next : HSBC cuts target price to 7785p from 9374p * Novozymes : JP Morgan cuts target price to DKK 440 from DKK 490 * Pagegroup : Citigroup raises to buy from neutral * Verbund AG : Deutsche Bank raises to buy from hold
Following is a summary of research actions on European companies reported by Reuters on Thursday. Stock entries are in alphabetical order.

* ADP : Citigroup raises price target to EUR 140 from EUR 133
* Angle Plc : Berenberg raises target price to 231p from 195p
* Angle Plc : Jefferies raises target price to 200p from 185p
* Ashtead Group Plc : Jefferies cuts target price to 5000p from 8000p
* ASML Holding NV : Piper Sandler cuts target price to EUR 630 from EUR 767
* Auto Trader : BofA Global Research cuts price objective to 800p from 810p
* Bakkavor : Berenberg cuts target price to 110p from 125p
* Bakkavor : Citigroup cuts price target to 105p from 140p
* Bayer AG : Citigroup raises price target to EUR 106 from EUR 102
* Bodycote

Is there any reason why it keeps getting mentioned has there been past connection?

Peanuts in a 100 bill market a fraction market share gives x 10 imho

What did the Abott CEO allude to the in advance chaps

So what happens if there is a total ban from EU??

Any idea on a partner for Bressay?

Can you post some info on it pls

Taking market share off Tui there rammed out having to draft in more plans charter to cope with demand

Done imho

Farms wired up see my post last Friday

Looks like a good run up on update to 40p imho

There short of stock so using some tricks but it's not working as more will buy knowing a FO on decent term will be nearer 10 bucks than 3 once completed

My money is on Delek with the connections from ithaca

Are there such plans afoot here mo?

Within 1 year poss? If so it would be £1

Not worth the risk in a volatile market play safe imho

https://www.bloomberg.com/news/articles/2022-05-14/uk-north-sea-sees-chance-for-political-reprieve-in-energy-crisis?srnd=premium-uk

Pe is far to low market is just waiting for more clarity that production is sustained month in month out which looks to now be the case.

Could also be a buyout target imho